Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo.

Jenike MA, Baer L, Summergrad P, Minichiello WE, Holland A, Seymour R.

Am J Psychiatry. 1990 Jul;147(7):923-8. Erratum in: Am J Psychiatry 1990 Oct;147(10):1393.

PMID:
2192564
2.

A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.

Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J.

Am J Psychiatry. 1990 Sep;147(9):1209-15.

PMID:
2143637
3.

Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.

Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA.

Psychopharmacol Bull. 1990;26(3):279-84.

PMID:
2274626
4.

A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.

Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowtiz MR, Lydiard B, et al.

Int Clin Psychopharmacol. 1995 Jun;10(2):57-65.

PMID:
7673657
5.

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.

Piccinelli M, Pini S, Bellantuono C, Wilkinson G.

Br J Psychiatry. 1995 Apr;166(4):424-43.

PMID:
7795913
6.

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.

Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K, et al.

Arch Gen Psychiatry. 1995 Apr;52(4):289-95.

PMID:
7702445
7.

A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.

Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K.

Int Clin Psychopharmacol. 1997 Nov;12(6):309-16.

PMID:
9547132
8.

Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.

Fineberg NA, Bullock T, Montgomery DB, Montgomery SA.

Int Clin Psychopharmacol. 1992 Jun;7 Suppl 1:43-7. Review. No abstract available.

PMID:
1517558
9.

Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.

Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH.

Am J Psychiatry. 1997 Sep;154(9):1293-5.

PMID:
9286191
10.

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.

Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC.

Arch Gen Psychiatry. 1995 Jan;52(1):53-60.

PMID:
7811162
11.

Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder.

Reimherr FW, Byerley WF, Ward MF, Lebegue BJ, Wender PH.

Psychopharmacol Bull. 1988;24(1):200-5. No abstract available.

PMID:
3290941
12.

Pharmacology of sertraline: a review.

Heym J, Koe BK.

J Clin Psychiatry. 1988 Aug;49 Suppl:40-5. Review.

PMID:
3045112
13.

Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.

Chouinard G.

Int Clin Psychopharmacol. 1992 Oct;7 Suppl 2:37-41. Review.

PMID:
1484177
14.

Selective serotonin reuptake inhibitors in OCD.

Montgomery SA, Bullock T, Fineberg N, Montgomery D.

Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:255A-256A. No abstract available.

PMID:
1498831
15.

A double-blind, placebo-controlled dose-finding study with sertraline.

Amin M, Lehmann H, Mirmiran J.

Psychopharmacol Bull. 1989;25(2):164-7. No abstract available.

PMID:
2690162
16.

Pharmacotherapy of obsessive compulsive disorder.

Goodman WK, McDougle CJ, Price LH.

J Clin Psychiatry. 1992 Apr;53 Suppl:29-37. Review.

PMID:
1532962
17.

Sertraline and mental retardation with obsessive-compulsive disorder.

Wiener K, Lamberti JS.

Am J Psychiatry. 1993 Aug;150(8):1270. No abstract available.

PMID:
8328577
18.

Pharmacologic management of obsessive-compulsive disorder.

Jackson CW, Morton WA, Lydiard RB.

South Med J. 1994 Mar;87(3):310-21.

PMID:
8134850
19.

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS.

Arch Gen Psychiatry. 1989 Jan;46(1):36-44.

PMID:
2491940
20.

Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.

Flament MF, Bisserbe JC.

J Clin Psychiatry. 1997;58 Suppl 12:18-22. Review.

Supplemental Content

Support Center